• 011-26907444
  • raghava@iiitd.ac.in

Detailed description page of AntiTbPdb

This page displays user query in tabular form.

antitb_1988 details
Primary information
IDantitb_1988
Peptide NameTeixobactin
SequenceFISQIISTAI
N-terminal ModificationFree
C-terminal ModificationFree
Chemical Modificationadenylation, C, condensation; MT, methylation (of phenylalanine); T, thiolation (carrier); and TE,thioesterase (Ile-Thr ring closure). NmPhe,N-methylated phenylalanin
Linear/ CyclicCyclic
Length10
ChiralityD
NatureCationic
SourceSynthetic
OriginNA
SpeciesMycobacterium tuberculosis
StrainMycobacterium tuberculosis H37Rv
Inhibition ConcentartionMIC= 0.125µg/ml
In vitro/In vivoIn vitro
Cell LineNA
Inhibition ConcentartionNA
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponseNA
Mechanism of ActionBinding of teixobactin to WTA precursor contributes to efficient lysis and killing, due to digestion of the cell wall by liberated autolysins
TargetCell wall
Combination TherapyNA
Other ActivitiesS. aureus (MSSA), S. aureus 110% serum, S. aureus (MRSA), Enterococcus faecalis (VRE), Enterococcus faecium (VRE), Streptococcus pneumoniae (penicillinR), Streptococcus pyogenes, Streptococcus agalactiae, Viridans group streptococci, B. anthracis, Clostridium difficile, Propionibacterium acnes, Haemophilus influenzae, Moraxella catarrhalis, Escherichia coli, Escherichia coli (asmB1), Pseudomonas aeruginosa, Klebsiella pneumoniae
Pubmed ID25561178
Year of Publication2015
3-D StructureNA